Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagen-targeted PET Imaging for Assessment of EGCG Effect in IPF
NCT06265532Phase 1Completed
- Start
- Feb 2024
- Primary completion
- Jan 2026
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of epigallocatechin gallate in idiopathic pulmonary fibrosis (IPF) (4 arms). Primary endpoint: Change in collagen probe uptake over the entire lungs at 12 weeks. Started Feb 2024; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT06265532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265532.